The search for an HIV cure: tackling latent infection
- PMID: 23481675
- DOI: 10.1016/S1473-3099(13)70043-4
The search for an HIV cure: tackling latent infection
Abstract
Strategies to eliminate infectious HIV that persists despite present treatments and with the potential to cure HIV infection are of great interest. One patient seems to have been cured of HIV infection after receiving a bone marrow transplant with cells resistant to the virus, although this strategy is not viable for large numbers of infected people. Several clinical trials are underway in which drugs are being used to activate cells that harbour latent HIV. In a recent study, investigators showed that activation of latent HIV infection in patients on antiretroviral therapy could be achieved with a single dose of vorinostat, a licensed anticancer drug that inhibits histone deacetylase. Although far from a cure, such studies provide some guidance towards the logical next steps for research. Clinical studies that use a longer duration of drug dosing, alternative agents, combination approaches, gene therapy, and immune-modulation approaches are all underway.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Similar articles
-
Eradication of HIV in infected patients: some potential approaches.Med Sci Monit. 2004 Jul;10(7):RA155-65. Epub 2004 Jun 29. Med Sci Monit. 2004. PMID: 15232518 Review.
-
Eliminating the latent HIV reservoir by reactivation strategies: advancing to clinical trials.Hum Vaccin Immunother. 2013 Apr;9(4):790-9. doi: 10.4161/hv.23202. Epub 2013 Apr 1. Hum Vaccin Immunother. 2013. PMID: 23563519 Free PMC article. Review.
-
Preclinical shock strategies to reactivate latent HIV-1: an update.Curr Opin HIV AIDS. 2016 Jul;11(4):388-93. doi: 10.1097/COH.0000000000000288. Curr Opin HIV AIDS. 2016. PMID: 27259046 Review.
-
Can HIV be Cured? Mechanisms of HIV persistence and strategies to combat it.Curr HIV Res. 2004 Apr;2(2):99-111. doi: 10.2174/1570162043484915. Curr HIV Res. 2004. PMID: 15078175 Review.
-
The development of immune-modulating compounds to disrupt HIV latency.Cytokine Growth Factor Rev. 2012 Aug-Oct;23(4-5):159-72. doi: 10.1016/j.cytogfr.2012.05.003. Epub 2012 Jul 4. Cytokine Growth Factor Rev. 2012. PMID: 22766356 Review.
Cited by
-
The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future.Br J Clin Pharmacol. 2015 Feb;79(2):182-94. doi: 10.1111/bcp.12403. Br J Clin Pharmacol. 2015. PMID: 24730660 Free PMC article. Review.
-
HIV-1 transcriptional regulation in the central nervous system and implications for HIV cure research.J Neurovirol. 2015 Jun;21(3):290-300. doi: 10.1007/s13365-014-0271-5. Epub 2014 Jul 25. J Neurovirol. 2015. PMID: 25060300 Free PMC article. Review.
-
The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?Cell Mol Immunol. 2015 Mar;12(2):128-38. doi: 10.1038/cmi.2014.75. Epub 2014 Aug 18. Cell Mol Immunol. 2015. PMID: 25132454 Free PMC article. Review.
-
Ending the HIV/AIDS epidemic in low- and middle-income countries by 2030: is it possible?F1000Res. 2016 Sep 15;5:2328. doi: 10.12688/f1000research.9247.1. eCollection 2016. F1000Res. 2016. PMID: 27703672 Free PMC article. Review.
-
The role of HIV integration in viral persistence: no more whistling past the proviral graveyard.J Clin Invest. 2016 Feb;126(2):438-47. doi: 10.1172/JCI80564. Epub 2016 Feb 1. J Clin Invest. 2016. PMID: 26829624 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical